Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical (LFCR) Total Current Liabilities: 2009-2025

Historic Total Current Liabilities for Lifecore Biomedical (LFCR) over the last 16 years, with May 2025 value amounting to $30.2 million.

  • Lifecore Biomedical's Total Current Liabilities fell 22.37% to $30.2 million in Q2 2025 from the same period last year, while for May 2025 it was $30.2 million, marking a year-over-year decrease of 22.37%. This contributed to the annual value of $30.2 million for FY2025, which is 22.37% down from last year.
  • According to the latest figures from Q2 2025, Lifecore Biomedical's Total Current Liabilities is $30.2 million, which was down 3.01% from $31.1 million recorded in Q1 2025.
  • Lifecore Biomedical's Total Current Liabilities' 5-year high stood at $195.6 million during Q4 2022, with a 5-year trough of $30.2 million in Q2 2025.
  • Its 3-year average for Total Current Liabilities is $36.5 million, with a median of $37.1 million in 2023.
  • Per our database at Business Quant, Lifecore Biomedical's Total Current Liabilities soared by 73.37% in 2022 and then slumped by 80.19% in 2023.
  • Over the past 5 years, Lifecore Biomedical's Total Current Liabilities (Quarterly) stood at $122.4 million in 2021, then surged by 59.83% to $195.6 million in 2022, then tumbled by 79.42% to $40.3 million in 2023, then fell by 12.33% to $35.3 million in 2024, then declined by 22.37% to $30.2 million in 2025.
  • Its last three reported values are $30.2 million in Q2 2025, $31.1 million for Q1 2025, and $35.3 million during Q4 2024.